SEC 13F Intelligence

Abacus Fcf Advisors LLC / ABBV

Abacus Fcf Advisors LLC’s Abbvie Inc Position

Does Abacus Fcf Advisors LLC own Abbvie Inc (ABBV)? Yes — 59.3K shares worth $13M (+2.90% of its 13F portfolio) as of Q1 2026, down from 101.9K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
59.3K
% of Portfolio
+2.90%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $993,000Q4 ’18Q1 ’19: $912,000Q2 ’19: $739,000Q3 ’19: $1MQ4 ’19: $1MQ4 ’19Q1 ’20: $1MQ2 ’20: $1MQ3 ’20: $2MQ1 ’21: $2MQ1 ’21Q2 ’21: $2MQ3 ’21: $2MQ4 ’21: $2MQ1 ’22: $6MQ1 ’22Q2 ’22: $3MQ3 ’22: $2MQ4 ’22: $2MQ1 ’23: $4MQ1 ’23Q2 ’23: $3MQ3 ’23: $4MQ4 ’23: $9MQ1 ’24: $12MQ1 ’24Q2 ’24: $10MQ3 ’24: $13MQ4 ’24: $19MQ1 ’25: $23MQ1 ’25Q2 ’25: $23MQ3 ’25: $29MQ4 ’25: $23MQ1 ’26: $13MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202659.3K$13M+2.90%
Q4 2025101.9K$23M+3.04%
Q3 2025126.3K$29M+3.89%
Q2 2025122.7K$23M+3.19%
Q1 2025108.1K$23M+3.56%
Q4 2024105.2K$19M+2.46%
Q3 202463.4K$13M+2.90%
Q2 202460.8K$10M+2.59%
Q1 202464.0K$12M+2.91%
Q4 202358.9K$9M+2.65%
Q3 202324.3K$4M+1.93%
Q2 202323.1K$3M+1.57%
Q1 202323.2K$4M+1.99%
Q4 202215.4K$2M+1.62%
Q3 202215.7K$2M+1.45%
Q2 202216.9K$3M+1.58%
Q1 202235.0K$6M+1.90%
Q4 202118.4K$2M+1.23%
Q3 202118.4K$2M+0.96%
Q2 202118.4K$2M+1.06%
Q1 202119.8K$2M+1.07%
Q3 202021.8K$2M+1.03%
Q2 202014.0K$1M+1.31%
Q1 202014.6K$1M+1.21%
Q4 201916.1K$1M+1.13%
Q3 201916.4K$1M+1.03%
Q2 201910.2K$739,000+0.61%
Q1 201911.3K$912,000+0.71%
Q4 201810.8K$993,000+0.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abacus Fcf Advisors LLC’s full portfolio or all institutional holders of ABBV.